medigraphic.com
SPANISH

Medicina Cutánea Ibero-Latino-Americana

ISSN 0210-5187 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 3

<< Back Next >>

Med Cutan Iber Lat Am 2010; 38 (3)

Biologic meaning of autoantibodies. Diagnostic procedures

Bielsa I
Full text How to cite this article

Language: Spanish
References: 5
Page: 109-116
PDF size: 150.04 Kb.


Key words:

Autoimmune diseases, immunofluorescence, immunoblot, ELISA.

ABSTRACT

The identification of autoantibodies in the sera of patients with autoimmune connective tissue diseases can be of significant value in the diagnosis, management and prognosis of these conditions, most of them with important cutaneous expression. However, the interpretation of the results depends on the type of antibody and the specific autoimmune connective tissue disease. Some autoantibodies have considerable disease specificity and thus can be of great diagnostic value (for example, anti-double-stranded DNA and Sm for systemic lupus erythematosus), but most autoantibodies fall into the disease non-specific category. So, basic understanding of key technical issues and concepts such as sensitivity, specificity, positive predictive value and negative predictive value, are important when considering the clinical significance of an antibody and the cost-benefit ratio of the various types of laboratory testing currently available for autoimmune diseases. Radioimmunoassay and immunoelectrophoresis were commonly used in the past. Immunoblot and immunofluorescence remain of important value although both, especially the former, are being slowly replaced by newer techniques such as the enzyme-linked immunosorbent assay (ELISA). ELISA is cheaper, less labor intensive, but is less specific and results need to be interpreted with caution. The classical ANA assay continues to be of great value into the world of autoimmune connective tissue diseases and understanding of its limitations is critically important to clinical and therapeutic decision-making.


REFERENCES

  1. Jacobe HT, Sontheimer RD. Autoantibodies encountered in patients with autoimmune connective tissue diseases. En: Bolognia JL, Jorizzo JL, Rapini RP, eds. Second Edition. Spain, Mosby Elsevier, 2008; 549-60.

  2. Cervera R, Plaza A. Guías de práctica clínica y de laboratorio. Autoanticuerpos y enfermedades autoinmunes. Sweden Diagnostics, SL Eds. Barcelona, 2006.

  3. Mutasim DF, Adams BB. A practical guide for serologic evaluation of autoimmune connective tissue diseases. J Am Acad Dermatol 2000; 42: 159-74.

  4. Bradwell AR, Hughes RG. Atlas of HEp-2 patterns., The Binding Site Ltd, eds. 3ª edición. Birmingham, 2007.

  5. Wenzel J, Gerdsen R, Uerlich M, Bauer R, Bieber T, Boehm I. Antibodies targeting extractable nuclear antigens: historical development and current knowledge. Br J Dermatol 2001; 145: 859-67.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Cutan Iber Lat Am. 2010;38